Sappi announced that its Biotech division has entered into an agreement with CellMark appointing CellMark as the non-exclusive sales agent for Sappi Biotech’s Hansa lignin products, produced in liquid and powder formats in South Africa at Sappi Tugela Mill.
CellMark operates a global sales, marketing, financing and logistics business aimed at consistently surpassing customer expectations.
Louis Kruyshaar, Sappi’s Biotech business leader, commented:
“We are really pleased to partner with CellMark which brings an excellent fit to our Biotech business at a stage when accelerated market penetration is key to attain our growth targets.
The partnership, which is built on common core values, will include a joint social investment initiative to benefit rural communities in South Africa.”
Lignins are commonly used as surfactants, binders, dispersers and emulsifying agents leading to the use of this renewable material produced from trees used in a large number of applications globally.
Sappi is the world’s largest producer of Lignosulphonates from operations in South Africa and Europe. The material is both used internally for bio-energy generation or beneficiated and processed to technical lignins for sale to global lignin markets.
South African Pulp and Paper Industries (Sappi) Limited was founded in 1936. The company is headquartered in Johannesburg. It is focuses on commodity paper products, pulp, chemical cellulose and forest and timber products for Southern Africa and export markets. In 2013, it was reported as the world’s largest producer of dissolving wood pulp.